Control Bionics (Australia) Alpha and Beta Analysis
| CBL Stock | 0.06 0.01 14.93% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Control Bionics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Control Bionics over a specified time horizon. Remember, high Control Bionics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Control Bionics' market risk premium analysis include:
Beta 1.95 | Alpha 1 | Risk 10.18 | Sharpe Ratio 0.13 | Expected Return 1.28 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Control |
Control Bionics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Control Bionics market risk premium is the additional return an investor will receive from holding Control Bionics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Control Bionics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Control Bionics' performance over market.| α | 1.00 | β | 1.95 |
Control Bionics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Control Bionics' Buy-and-hold return. Our buy-and-hold chart shows how Control Bionics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Control Bionics Market Price Analysis
Market price analysis indicators help investors to evaluate how Control Bionics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Control Bionics shares will generate the highest return on investment. By understating and applying Control Bionics stock market price indicators, traders can identify Control Bionics position entry and exit signals to maximize returns.
Control Bionics Return and Market Media
The median price of Control Bionics for the period between Fri, Oct 31, 2025 and Thu, Jan 29, 2026 is 0.065 with a coefficient of variation of 21.44. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.06, and mean deviation of 0.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | How Ekso Bionics Holdings Inc. stock reacts to oil prices - Quarterly Trade Report Low Risk Investment Opportunities - fcp.pa.gov.br | 11/05/2025 |
2 | Rise and Shine Everything you need to know before the ASX opens - The Chronicle The Chronicle | 11/12/2025 |
3 | Control Bionics Ltd. Announces Successful Shareholder Meeting Outcomes - TipRanks | 11/24/2025 |
4 | Control Bionics Issues 8 Million CEO Options in New Incentive Scheme - The Globe and Mail | 11/27/2025 |
5 | Control Bionics to Fully Acquire Neuro Elite Athletics - TipRanks | 12/02/2025 |
6 | Control Bionics Finalises All-Share Acquisition of NeuroBounce Owner Neuro Elite Athletics - TipRanks | 12/31/2025 |
7 | Control Bionics signs US distribution agreement with PRC Saltillo - marketscreener.com | 01/28/2026 |
About Control Bionics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Control or other stocks. Alpha measures the amount that position in Control Bionics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Control Bionics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Control Bionics' short interest history, or implied volatility extrapolated from Control Bionics options trading.
Build Portfolio with Control Bionics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Control Stock Analysis
When running Control Bionics' price analysis, check to measure Control Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Control Bionics is operating at the current time. Most of Control Bionics' value examination focuses on studying past and present price action to predict the probability of Control Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Control Bionics' price. Additionally, you may evaluate how the addition of Control Bionics to your portfolios can decrease your overall portfolio volatility.